Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
6
×
fda
6
×
life sciences
national blog main
national top stories
new york blog main
roche
6
×
san francisco blog main
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
deals
cancer immunotherapy
investing
merck
startups
vertex pharmaceuticals
amgen
bristol-myers squibb
companion diagnostic
What
cancer
roundup
ahead
annual
asco
bio
clinical
days
drug
fda
medicine
meeting
oncology
society
time
acquire
agreed
alliance
ambien
american
approved
ash
attendees
attention
barcelona
big
billion
biotech
branded
bristol
broad
buy
calls
camp’s
cash
changing
chicago
choices
city
color
Language
unset
Current search:
roche
×
cancer
×
fda
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More